Keratopathy Clinical Trials in Portland, Oregon
2 recruitingPortland, Oregon
Showing 1–2 of 2 trials
Recruiting
Phase 3
Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2
Neurotrophic Keratopathy
ReGenTree, LLC70 enrolled36 locationsNCT05555589
Recruiting
OCT in Fuchs' Dystrophy
Pseudophakic Bullous KeratopathyFuchs Dystrophy
Oregon Health and Science University60 enrolled1 locationNCT04258787